Rapamycin (sirolimus) ocular formulation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rapamycin (sirolimus) ocular formulation, covering 2013-01-10 to 2013-01-10. Get the full timeline:
Most recent: Clinical Trial Update: Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema [Phase 2]